/Companies

Lockebio

Founded 2019 · 9 employees on LinkedIn · 3 known investors

Find your way into Lockebio

Sign up to see every warm intro you have to Lockebio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lockebio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Locke Bio operates a white-labeled digital health platform enabling brands to launch integrated telehealth services with telemedicine consultations, patient intake, pharmacy networks, and payment processing. The platform serves direct-to-consumer brands seeking to distribute prescription drugs and healthcare services with an e-commerce experience.

Founders & leadership

Lockebio was founded in 2019 by Cathy Tie.

CTCathy Tie
Cathy TieFounder and CEOFounder of Ranomics · Thiel Fellow 2015
JRJosh Rosaasen
Josh RosaasenCOOJosh Rosaasen is COO of Locke Bio, a digital health platform providing white-label telehealth services. He has prior experience as a management consultant in retail and in sales and market analysis roles within the cannabis industry.

Investors · 3

Frequently asked questions

What does Lockebio do?
Locke Bio operates a white-labeled digital health platform enabling brands to launch integrated telehealth services with telemedicine consultations, patient intake, pharmacy networks, and payment processing. The platform serves direct-to-consumer brands seeking to distribute prescription drugs and healthcare services with an e-commerce experience.
Who founded Lockebio?
Lockebio was founded by Cathy Tie in 2019.
Who are Lockebio's investors?
Lockebio's investors include Gaingels, IKJ Capital, Ten13.